Abstract
Aim: Vitamin D modulates biological processes; an influence of vitamin D levels and genetic variants was identified concerning hepatitis B virus infection. We evaluated the role of some SNPs of vitamin D pathway genes in some clinical features of hepatitis B affected patients treated with pegylated interferon. Methods: We investigated SNPs in IL-28B, CYP27B1, CYP27A1, CYP24A1, VDBP and VDR genes, through real-time PCR. Results: VDRApaI SNP was associated to viral load and HBsAg presence at different timings. In logistic regression analyses, VDRApaI AA genotype predicted baseline viral load >6 Log IU/ml (marker of nonresponse), and both virological and biochemical responses. Conclusion: Pharmacogenetic data could help physicians in the prediction of patients with higher probability to achieve a good response.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 651-661 |
Numero di pagine | 11 |
Rivista | Pharmacogenomics |
Volume | 18 |
Numero di pubblicazione | 7 |
DOI | |
Stato di pubblicazione | Pubblicato - mag 2017 |
Pubblicato esternamente | Sì |